Atlas Trials

A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine

Clinical trial NCT04102995 · COMPLETED

Trial details

NCT number
NCT04102995
Sponsor
Asarina Pharma
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Menstrual Migraine
Start date
2019-08-27
Primary completion
2021-05-15
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.